A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
Leaders from Henry Ford Health System discuss the value of advancing DEI efforts within the supply chain.
The Journal of Healthcare Contracting | Conductiv's Chris Gormley discusses recent purchased services trends and strategies for providers to tap into savings.
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
Forbes | A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
See how we're leveraging our rich data sets to uncover new oncology insights.
Financial Times | Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
JAMA Network | This paper examines the uptake and accuracy of diagnosis for COVID-19 in U.S. hospitals.
TCTMD | Premier's Ning Rosenthal discusses findings from a recent study that looked at patients with COVID-19 in US acute care hospitals.